Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hypertonic Saline (3%) vs Normal Saline for Post-Operative Pain in Symptomatic Irreversible Pulpitis
NCT07701551Phase 4Not yet recruiting
- Sponsor
- Cairo University
- Start
- Aug 2026
- Primary completion
- Jan 2027
01
Overview
A Phase 4 trial of hypertonic saline in irreversible pulpitis, sponsored by Cairo University. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
hypertonic saline
03
Conditions
irreversible pulpitis
Beyond the preview
Go deeper on NCT07701551.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07701551.